20675 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Microorganisms or materials therefrom; Viruses; Subviral particles; Bacteriophages Rhabdovirus, e.g. vesicular stomatitis virus
Macrophage depletion and vesicular stomatitis virus for treatment of cancer
#2Recombinant rhabdovirus encoding for a gasdermin
#3METHOD FOR TREATMENT OF TUMOR BY USING RECOMBINANT ONCOLYTIC VIRUS IN COMBINATION WITH SMALL-MOLECULE ANTICANCER DRUG
#4MANUFACTURING SYSTEMS AND METHODS FOR CELLULAR THERAPEUTIC PLATFORMS
#5USE OF ENGINEERED JURONA VIRUS (JURV) AS AN ONCOLYTIC VIRUS PLATFORM FOR HUMAN CANCERS
#6Recombinant Viral Genomes and Related Compositions and Methods
#7MORRETON VIRUSES AND METHODS OF USE
#8TRANSCRIPTIONAL AND TRANSLATIONAL DUAL REGULATED ONCOLYTIC HERPES SIMPLEX VIRUS VECTORS
#9Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein
#10VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#11GENETICALLY MODIFIED UNGULATE CELLS AND THEIR USES IN CANCER THERAPY
#12ONCOLYTIC VIRUS AND USE THEREOF
#13FORMULATIONS TO STABILIZE VIRUS-BASED THERAPEUTICS
#14FORMULATIONS TO STABILIZE VIRUS-BASED THERAPEUTICS
#15ARMED CHIMERIC ONCOLYTIC VIRUSES
#16RECOMBINANT ONCOLYTIC VIRUS, AND CONSTRUCTION METHOD THEREFOR AND USE THEREOF
#17COMPOSITIONS AND METHODS FOR ENHANCING PRODUCTION, GROWTH, SPREAD, OR ONCOLYTIC AND IMMUNOTHERAPEUTIC EFFICACY OF INTERFERON-SENSITIVE VIRUSES
#18PHARMACEUTICAL COMPOSITIONS COMPRISING VANADIUM SALTS
#19ONCOLYTIC VIRUS AND USE THEREOF
#20ARTIFICIAL ONCOLYTIC VIRUSES AND RELATED METHODS
#21RECOMBINANT VSV FOR THE TREATMENT OF BLADDER CANCER
#22ARTIFICIAL ONCOLYTIC VIRUSES AND RELATED METHODS
#23VESICULAR STOMATITIS VIRUSES
#24CANINE DISTEMPER VIRUS HEMAGGLUTININ AND FUSION POLYPEPTIDES
#25METHODS AND MATERIALS FOR TREATING CANCER
#26RECOMBINANT RHABDOVIRUS ENCODING FOR CCL21
#27REPLICATION-COMPETENT VESICULAR STOMATITIS VIRUSES
#28COMPOSITIONS AND METHODS FOR GLIOBLASTOMA TREATMENT
#29ONCOLYTIC VIRUSES AS ADJUVANTS
#30ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR FOR TREATING TUMORS
#31COMPOSITIONS AND METHODS OF USE OF ONCOLYTIC VIRUS LIKE VESICLES
#32Composition comprising PIC for treatment of cancer
#33THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS
#34TARGETED CANCER THERAPY
#35METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS
#36PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TUMOR OR CANCER, AND APPLICATION THEREOF
#37Chimeric vesiculoviruses and methods of use
#38POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR
#39METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS
#40SEQUENTIAL HETEROLOGOUS BOOST ONCOLYTIC VIRAL IMMUNOTHERAPY
#41VSV CHIMERIC VECTORS
#42Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein
#43METHODS AND MATERIALS FOR TREATING CANCER
#44NON-REPLICATING VIRUS-DERIVED PARTICLES AND USES THEREOF
#45Methods for treatment of cancer using chikungunya-VSV chimeric virus
#46METHODS OF TREATING CANCER USING COMBINATION THERAPY
#47USES AND METHODS FOR ONCOLYTIC VIRUS TARGETING OF IL-4/IL-13 AND FUSIONS THEREOF
#48VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#49ONCOLYTIC RHABDOVIRUS
#50CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER
#51VACCINE COMPOSITION
#52Recombinant plasma membrane-based vesicle, for treating cancer
#53Compositions and methods for glioblastoma treatment
#54ONCOLYTIC VIRUSES AS ADJUVANTS
#55SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#56Vesicular stomatitis viruses
#57Compositions and methods for enhancing production, growth, spread, or oncolytic and immunotherapeutic efficacy of interferon-sensitive viruses
#58Recombinant rhabdovirus encoding for CCL21
#59Replication-competent vesicular stomatitis viruses
#60RECOMBINANT ONCOLYTIC VIRUS
#61Oncolytic virus for expression of immune checkpoint modulators
#62RECOMBINANT ONCOLYTIC VIRUSES FOR TREATMENT OF METASTATIC CANCERS
#63THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS
#64Therapeutic agents and uses thereof for drugs for treatment of tumors and/or cancers
#65Methods and materials for treating cancer
#66PSEUDOTYPED ONCOLYTIC RHABDOVIRUSES AND THEIR USE IN COMBINATION THERAPY
#67Vaccine composition
#68Pharmaceutical composition comprising nanoperforator for preventing or treating viral infectious diseases
#69Vaccine composition
#70Oncolytic rhabdovirus expressing IL12
#71VSV/NDV hybrid viruses for oncolytic therapy of cancer
#72COMBINATION PRIME: BOOST THERAPY
#73Chimeric VSV virus compositions and methods of use thereof for treatment of cancer
#74Composition comprising PIC for treatment of cancer
#75Methods and materials for treating cancer
#76ONCOLYTIC RHABDOVIRUS
#77Targeted cancer therapy
#78Compositions and methods for enhancing virus replication
#79Vesicular stomatitis viruses
#80Replication-competent vesicular stomatitis viruses
#81Method of Vaccination Comprising a Histone Deacetylase Inhibitor
#82SMC combination therapy for the treatment of cancer
#83Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof
#84ONCOLYTIC RHABDOVIRUS
#85Replication-competent vesicular stomatitis viruses
#86Methods and materials for treating cancer
#87Vesicular stomatitis viruses
#88Chimeric VSV virus compositions and methods of use thereof for treatment of cancer
#89Compositions and methods for glioblastoma treatment
#90In vivo individualized systemic immunotherapeutic method and device
#91Compositions and methods for enhancing virus replication
#92Vaccine composition
#93Recombinant VSV for the Treatment of Tumor Cells
#94Non-replicating virus-derived particles and uses thereof
#95COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRAIN CANCERS
#96Oncolytic rhabdovirus
#97Compositions and methods for enhancing virus efficacy
#98Replication-competent vesicular stomatitis viruses
#99Neuron generation, regeneration and protection
#100Compositions, methods and uses for treating solid tumors using LCMV-GP-VSV pseudotype vectors
#101Method of vaccination comprising a histone deacetylase inhibitor
#102Compositions and methods for glioblastoma treatment
#103Methods and compositions for treating tumors using myeloid derived suppressor cells
#104ONCOLYTIC RHABDOVIRUS
#105Oncolytic rhabdovirus
#106Modulating oncolytic vesicular stomatitis virus (VSV) with statins for cancer treatment
#107IMMUNOSELECTION OF RECOMBINANT VESICULAR STOMATITIS VIRUS EXPRESSING HIV-1 PROTEINS BY BROADLY NEUTRALIZING ANTIBODIES
#108COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATTENUATED ONCOLYTIC VIRUSES
#109Methods and materials for treating cancer
#110Oncolytic rhabdovirus
#111Compositions and methods for enhancing virus efficacy
#112Neuron generation, regeneration and protection
#113Engineered synergistic oncolytic viral symbiosis
#114Oncolytic rhabdovirus
#115AMPLIFICATION OF CANCER-SPECIFIC ONCOLYTIC VIRAL INFECTION BY HISTONE DEACETYLASE INHIBITORS
#116STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY
#117TRANSGENIC ONCOLYTIC VIRUSES AND USES THEREOF
#118Recombinant VSV For The Treatment of Tumor Cells
#119DISPARATE SUICIDE CARRIER CELLS FOR TUMOR TARGETING OF PROMISCUOUS ONCOLYTIC VIRUSES
#120Therapy for primary and metastatic cancers
#121ONCOLYTIC VIRUS
#122PURGING OF CELLS USING VIRUSES
#123Recombinant mutants of rhabdovirus and methods of use thereof